高级搜索

肝癌组织中FMNL-2和MMP-2的表达及临床病理分析

罗 佳, 章敬成, 刘繁荣, 吴冬梅, 廖首生, 杨宇晴

罗 佳, 章敬成, 刘繁荣, 吴冬梅, 廖首生, 杨宇晴. 肝癌组织中FMNL-2和MMP-2的表达及临床病理分析[J]. 肿瘤防治研究, 2014, 41(05): 460-463. DOI: 10.3971/j.issn.1000-8578.2014.05.026
引用本文: 罗 佳, 章敬成, 刘繁荣, 吴冬梅, 廖首生, 杨宇晴. 肝癌组织中FMNL-2和MMP-2的表达及临床病理分析[J]. 肿瘤防治研究, 2014, 41(05): 460-463. DOI: 10.3971/j.issn.1000-8578.2014.05.026
LUO Jia, ZHANG Jingcheng, LIU Fanrong, WU Dongmei, LIAO Sh ousheng, YANG Yuqing. Expression of FMNL-2 and MMP-2 in Primary Hepatocellular Carcinoma and Its Clinicopathological Characteristics[J]. Cancer Research on Prevention and Treatment, 2014, 41(05): 460-463. DOI: 10.3971/j.issn.1000-8578.2014.05.026
Citation: LUO Jia, ZHANG Jingcheng, LIU Fanrong, WU Dongmei, LIAO Sh ousheng, YANG Yuqing. Expression of FMNL-2 and MMP-2 in Primary Hepatocellular Carcinoma and Its Clinicopathological Characteristics[J]. Cancer Research on Prevention and Treatment, 2014, 41(05): 460-463. DOI: 10.3971/j.issn.1000-8578.2014.05.026

肝癌组织中FMNL-2和MMP-2的表达及临床病理分析

基金项目: 江西省教育厅科技计划资助项目(20100611);江西省科技支撑计划重点项目(2010BSA13100)
详细信息
    作者简介:

    罗佳(1985 -),女,硕士在读,主要从事肿瘤病理学的研究

    通讯作者:

    刘繁荣,E-mail:liufanrong@163.com

  • 中图分类号: R735.7

Expression of FMNL-2 and MMP-2 in Primary Hepatocellular Carcinoma and Its Clinicopathological Characteristics

  • 摘要: 目的 探讨肝癌及癌旁组织中FMNL-2和MMP-2的蛋白表达及与临床病理特征的关系。方法 采用免疫组织化学MaxvisionTM法检测100例肝癌及癌旁组织中FMNL-2和MMP-2的蛋白表达情况,应用图文分析软件Image-Pro Plus6.0测定FMNL-2和MMP-2的蛋白累积吸光度值(IOD),采用SPSS19.0 软件统计分析。结果 肝癌及癌旁组织中FMNL-2蛋白IOD值分别为(90 748.36±46 276.91)和(39 075.46±24 763.12),MMP-2蛋白IOD值分别为(87 969.46±27 131.77)和(59 517.72±20 218.23),两组差异均有统计学意义(P<0.05);FMNL-2在伴与不伴肝硬化组中IOD值分别为(47 471.96±40 273.54)和(72 123.41±45 517.93)(P<0.05);MMP-2在HBsAg阳性或阴性组中IOD值分别为(77 668.34±27 682.79)和(64 585.83±26 173.62)(P<0.05),在有无转移组中IOD值分别为(63 854.73±21 730.42)和(77 218.05±28 930.01)(P<0.05),差异有统计学意义;并且肝癌及癌旁组织中FMNL-2 和MMP-2蛋白表达呈正相关(r=0.240,P=0.016)。结论 在肝癌发生、发展过程中存在FMNL-2和MMP-2蛋白异常表达,联合监测两者蛋白表达可能会有助于肝癌的诊断。

     

    Abstract: Objective To invesstigate the expression of FMNL-2 and MMP-2 in hepatocellular carcinoma (HCC) and the adjacent tissues, and to detect their relationship with the clinicopathological features. Methods The protein expression of FMNL-2 and MMP-2 were detected by immunohistochemistry MaxvisionTM method in the cancer tissues and adjacent tissues from 100 patients. Integrated optical density (IOD ) of immunohistochemical image was estimated by Image-ProPlus 6.0 software. Statistical analysis was performed by SPSS19.0 software. Results IOD of FMNL-2 between cancer tissues and adjacent tissues were (90 748.36±46 276.91)and (39075.46±24763.12);IOD of MMP-2 between cancer tissues and adjacent tissues were (87 969.46±27 131.77) and (59 517.72±20 218.23) (P<0.05); IOD of FMNL-2 between cirrhosis of liver tissue and non-cirrhosis liver tissue were(47 471.96±40 273.54) and (72 123.41±45 517.93), respectively(P<0.05); IOD of MMP-2 between HBsAg positive and negative group were (77 668.34±27 682.79) and (64 585.83±26173.62),respectively(P<0.05),IOD of MMP-2 between metastasis and without metastasis group were(63 854.73±21 730.42) and (77 218.05±28 930.01)(P<0.05),FMNL-2 expression was positively correlated to that of MMP-2 in cancer tissues and adjacent tissues (r=0.240,P=0.016). Conclusion FMNL-2 and MMP-2 proteins are abnormally expressed in hepatocellular carcinoma, indicating that detection of FMNL-2 and MMP-2 proteins may be helpful for diagnosis of hepatocellular carcinoma.

     

  • [1] Jemal A, Bray F, Center MM,et al.Global cancer statistics[J]. CA Cancer J Clin,2011,61(2):69-90.
    [2] Pang RW, Joh JW, Johnson PJ,et al.Biology of hepatocellular carcinoma[J]. Ann Surg Oncol,2008,15(4):962-71.
    [3] Zhu XL, Liang L,Ding YQ.The expression and clinical signifi cance of formlin-like 2 in colorectal carcinoma[J]. Zhongguo Zong He Lin Chuang,2008,24(5):401-4. [朱曦龄,梁莉,丁彦青. FMNL2 在结直肠癌组织中的表达及其临床意义[J].中国综合临床, 20 08,24(5):401-4.]
    [4] Katoh M, Katoh M. Identifi cation and characterization of human FMNL1, FMNL2 and FMNL3 genes in silico[J].Int J Oncol,2003, 22 (5):1161-8.
    [5] Courtemanche N, Pollard TD. Determinants of formin homology 1 (FH1) domain function in actin fi lament elongation by formins[J]. J Biol Chem,2012,287(10):7812-20.
    [6] Paul AS, Pollard TD. The role of the FH1 domain and profi lin in formin-mediated actin-fi lament elongation and nucleation[J]. Curr Biol,2008,18(1):9-19.
    [7] Kitzing TM, Wang Y, Pertz O, et al.Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC[J]. Oncogene,2010,29 (16) :2441-8.
    [8] Li YF, Xiao FM, Liang L,et al.Bioinformatic Analysis of the Gene FMNL2 in Clorectal Cancer Metastasis[J]. Zhongguo Zhong Liu Lin Chuang,2011,38(7):361-6.[李余发,肖法嫚,梁莉,等.大 肠癌转移相关基因FMNL2的生物信息学分析[J].中国肿瘤临 床,2011,38(7):361-6.]
    [9] Yamamoto H,Itoh F, Adachi Y,et al.Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma[J].Gastroenterology,1997,112(4):1290-6.
    [10] Yang C, Zeisberg M, Lively J C, et al.Integrin α1β1 and α2β1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment[J]. Cancer Res, 2003, 63(23): 83 12-7.
    [11] Liang L,Li X,Zhang X,et al.MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2[J].Gastroenterology,2013,144(3): 624-35.
计量
  • 文章访问数:  1616
  • HTML全文浏览量:  304
  • PDF下载量:  730
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-04-01
  • 修回日期:  2013-07-17
  • 刊出日期:  2014-05-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭